Life-Improving Decisions in ALS: Respiratory Support Options

Life-Improving Decisions in ALS: Respiratory Support Options

Amyotrophic lateral sclerosis (ALS) is a disease that progressively shuts down your muscles by attacking certain cells in the brain and spinal cord that are needed to keep muscles moving. Eventually, patients will lose their mobility, have trouble moving, walking, swallowing and even breathing. But what exactly is ALS?…

FDA Names Ibudilast an Orphan Drug as Possible ALS Treatment

The U.S. Food and Drug Administration (FDA) has designated  MediciNova’s Ibudilast (MN-166) an orphan drug as a potential treatment for amyotrophic lateral sclerosis (ALS). Ibudilast is a first-in-class, orally bioavailable small molecule phosphodiesterase (PDE)-4 and -10 inhibitor and a macrophage migration inhibitory factor (MIF) inhibitor that suppresses pro-inflammatory cytokines and promotes neurotrophic factors.

Pastor Battles ALS but Still Inspires Others

In this Houston Methodist video, we get to meet Kevin Kinchen. Kevin was diagnosed with amyotrophic lateral sclerosis (ALS) six years ago, but he hasn’t let that stop him from getting on with his life.  Nanci is a much-loved Hollywood publicist who was diagnosed with amyotrophic lateral sclerosis (ALS)…

What Is the Penn’s Comprehensive ALS Center?

Patients with amyotrophic lateral sclerosis (ALS) experience a gradual loss of the ability to walk, swallow and even breathe, and there’s no cure. It’s incredibly important that patients seek specialized treatment to address the different aspects of the disease. Find out seven ways to diagnose ALS. In this…

Turmeric Ginger Tea Recipe

Turmeric & Ginger are Antioxidants Fall is the perfect season to drink spice teas. This ginger and turmeric tea recipe is chock-full of antioxidants. Merriam Webster defines antioxidants as a substance (as beta-carotene or vitamin C) that inhibits oxidation or reactions promoted by oxygen, peroxides, or free radicals…

New Preclinical Data of Masitinib for ALS Presented at 4 Scientific Meetings This Year

AB Science has been invited to present new preclinical studies on masitinib in the treatment of amyotrophic lateral sclerosis (ALS) at four international meetings this year. These were the main findings from the series of preclinical studies: Proof of concept data from the preclinical trials of masitinib showed that the investigational drug “targets…

Living with ALS: Nanci Ryder’s Story

Find out more about the story of Nanci Ryder in this ALS Association video. Nanci is a much-loved Hollywood publicist who was diagnosed with amyotrophic lateral sclerosis (ALS) in 2014. Read about the four ALS heroes the ALS Association chose to honor for outstanding contributions.  The ALS Association’s…